All News

A new FDA policy would assess blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.

This treatment approach helps reduce symptoms and future exacerbations triggered by dust mites, pet dander, pollen.

Health systems must address drivers of attrition, turnover.

Although some pharmacy employees have left the profession, others have stayed but changed direction.

Patients with C. difficile who received clonal bacteria populations via biotherapeutic injection were able to repopulate their microbiota with commensal bacteria.

Individualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.

Josh Marsh, vice president and general manager of Sonexus Access and Patient Support at Cardinal Health, discussed how patient assistance programs are leveraging technology.

Tackling racial disparities among health care providers can help improve disparities faced by patients.

Closely monitored, decentralized trials have also been shown to improve electronic patient reported outcomes to 92% compliance, according to ObvioHealth.

A novel collaboration between the University of Pennsylvania and US Anesthesia Partners is working to drive evidence-based change in benzodiazepine use.

Study of cell exhaustion in immunotherapy-resistant tumors could significantly improve the benefits of cancer immunotherapy for patients with treatment resistant types of cancer.

An FDA committee voted 17-0 to make the once-daily birth control medication Opill available OTC after deciding the benefits outweigh any potential harms.

Redefining technician roles boosts workflow efficiencies, strengthens pharmacies' bottom lines.

Commonly, essential yet routine and time-consuming tasks, such as answering phone calls, scheduling appointments, or other administrative work, prevent health care workers from focusing on more value-added and enjoyable job functions.

The extra surveillance by a specialty pharmacy teams allows for faster initiation of therapy, earlier recognition of adverse effects, and promotes patient safety.

US Preventive Services Task Force also called for more research into how to address screening and treatment disparities faced by racial and ethnic minorities.

Importantly, Sullivan said data show that adverse events in the home infusion environment are no higher than in any other setting.

During a fireside chat, USP CEO Ronald T. Piervincenzi, PhD, and the Honorable Dr. Oh Yu-Kyoung, Minister of MFDS, Republic of Korea, discuss interruptions to the medical supply chain and the interventions used.

As patents expire, the development of biosimilars may increase, opening up new opportunities to compare efficacies of these drugs.

Naiffer Romero, MSc, MPH, discusses his work at U.S. Pharmacopeia to regulate nitrosamine impurities and ensure medication quality.

Dapagliflozin was established as the first SGLT2 inhibitor that demonstrated a mortality benefit for cardiovascular death from heart failure.

With or without US federal regulation, CBD companies should provide consumers with more transparent information about their products.

Joanna Lewis and Pooja Lakshmin, MD, discuss Lakshmin's new book, "Real Self-Care," and women's mental health.

The impact that socioeconomic inequities can have on a child’s hippocampal volume may have implications for their success and experience pursuing educational endeavors.

Approximately 43 total specialty drugs come to the market each year, on average.

Shweta S. Namjoshi, MD, MPH, CNSC, discusses the role of the pharmacists in gastrointestinal care and the differences in care for pediatrics and adults.

Evidence suggest better outcomes results when a program is responsive to the significant needs of this population.

Findings may offer insight into new strategies to tackle skin cancer in patients already treated with a prior line of therapy.